2014
DOI: 10.1111/vop.12155
|View full text |Cite
|
Sign up to set email alerts
|

Stability of 1% voriconazole solution in a constant‐rate infusion pump for topical ocular delivery to horses

Abstract: Voriconazole 1% solution is not compatible for use in a CRI/SPL unit at temperatures between 23 and 40 °C. Voriconazole 1% solution is stable in the commercial glass vial when stored at controlled temperatures as high as 40 °C for up to 30 days.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…Antimicrobial administration through SPLs has been previously reported to reduce the incidence of infection. [1][2][3][4][7][8][9][10][12][13][14][15]17,[21][22][23][24][25] In the present study, SPL systems with antimicrobials administered through them experienced fewer ocular complications than those without antimicrobials administered through them. Interestingly, SPLs that did not have antimicrobials administered through them did not experience any nonocular complications.…”
Section: Discussionmentioning
confidence: 76%
See 2 more Smart Citations
“…Antimicrobial administration through SPLs has been previously reported to reduce the incidence of infection. [1][2][3][4][7][8][9][10][12][13][14][15]17,[21][22][23][24][25] In the present study, SPL systems with antimicrobials administered through them experienced fewer ocular complications than those without antimicrobials administered through them. Interestingly, SPLs that did not have antimicrobials administered through them did not experience any nonocular complications.…”
Section: Discussionmentioning
confidence: 76%
“…
O phthalmic disease presents a treatment challenge in equids with corneal and anterior uveal tract conditions that need frequent topical medications, including ophthalmic solutions and ointments. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16] With increased frequency of topical medication application, horses sometimes become progressively evasive or violent toward the handler, creating a dangerous environment for the horse and the caretaker. 1,11,13,[16][17][18][19][20] Treatment failure due to the inability to administer an appropriate quantity or frequency of medication may result in progression of disease or enucleation.
…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…17 Although topical administration of voriconazole solution may be performed easily by using a subpalpebral lavage system, continuous rate infusion (CRI) of voriconazole solution using a CRI pumps is not recommended because voriconazole becomes unstable owing to the high temperature in CRI pumps. 18 Furthermore, during long treatment periods for equine keratomycosis, use of a CRI system or frequent topical administration may become difficult because of CRI device-related issues and/ or horses being fractious. 17,19 Oral administration of voriconazole achieves excellent systemic bioavailability, 20 and, based on published minimum inhibitory concentration (MIC) results, dosing at 4.0 mg/kg once daily achieves adequate plasma concentrations for the treatment of systemic aspergillosis in horses.…”
Section: Introductionmentioning
confidence: 99%